Arrowstreet Capital
AHCO icon

Arrowstreet Capital’s AdaptHealth AHCO Stock Holding History

Arrowstreet Capital’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Buy
847,085
+395,668
+88% +$4.05M 0.01% 942
2025
Q4 		$4.5M Buy
451,417
+343,155
+317% +$3.28M ﹤0.01% 1170
2025
Q3 		$969K Sell
108,262
-278,056
-72% -$2.58M ﹤0.01% 1606
2025
Q2 		$3.64M Buy
+386,318
New +$3.41M ﹤0.01% 1275
2022
Q3 		– Sell
-37,302
Closed -$673K – 1249
2022
Q2 		$673K Buy
+37,302
New +$606K ﹤0.01% 1023
2021
Q2 		– Sell
-177,986
Closed -$6.54M – 1835
2021
Q1 		$6.54M Buy
177,986
+77,355
+77% +$2.73M 0.01% 1058
2020
Q4 		$3.78M Buy
100,631
+53,950
+116% +$1.67M 0.01% 1332
2020
Q3 		$1.02M Buy
+46,681
New +$980K ﹤0.01% 1810

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital's AHCO Position: Q1 2026 in Review

Arrowstreet Capital increased its AdaptHealth (AHCO) stake by 88% in Q1 2026, buying an estimated $4.05M and bringing the position to 847,085 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #942.

Arrowstreet Capital first reported a position in AHCO in Q3 2020 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Arrowstreet Capital held 847,085 shares of AdaptHealth worth $10.1M as of Q1 2026.
  • Arrowstreet Capital bought 395,668 AdaptHealth shares in Q1 2026, an estimated $4.05M.
  • AdaptHealth made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #942 holding.
  • Arrowstreet Capital first reported a position in AdaptHealth in Q3 2020 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.